CClinicalTrials.gg
RecruitingNCT01515904STOMPUpdated Sep 13, 2022

Evaluation of the SickKids Team Obesity Management Program

An observational study in Obesity, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-09-13.

Sponsored by The Hospital for Sick Children · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Started Apr 2011; still recruiting 15 years 6 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
400
Ages
12 Years to 18 Years
Sex
All
01

Study summary

In January 2010 a new interdisciplinary clinic (STOMP) was created to provide care for children and adolescents with severe 'complex' obesity. As part of the program, a subset of adolescents undergo bariatric surgery. There is a paucity of literature evaluating outcomes of children and adolescents participating in a 'clinical' setting and even fewer reports of outcomes of severely obese pediatric patients. Previously, the investigators evaluated clinical outcomes of children with craniopharyngioma and hypothalamic obesity attending an outpatient interdisciplinary program at SickKids (The Comprehensive Care Clinic for Children with Central Tumours) and found significant benefit to those attending, including reduction of weight gain (or weight loss), improved psychosocial functioning, and increased care satisfaction. STOMP is a natural extension of this program, incorporating some core elements (e.g., interdisciplinary team, frequent visits, individualized care plans for medically-complex adolescents) and building on other aspects, such as increased psychosocial intervention; involvement of a "key worker" (nurse practitioner) to support families; provision of continuity of care with other health providers in all settings, community services and schools; a more diverse patient population; and group support sessions. Evaluation of the outcomes of this clinic is needed to inform best practice for children and adolescents with severe complex obesity

Read the detailed description

The primary objective is to conduct an evaluation of the STOMP clinic as a model of care with a specific focus on: (i) patient outcomes (anthropometric, metabolic, and psychosocial); and (ii) care coordination and care satisfaction.

Patient outcomes will be compared against baseline evaluation data over time, and to a control group of patients not enrolled in the program, but who expressed interest in the program and were unable to attend.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • obesity management
  • adolescents
  • body mass index
  • treatment outcomes
  • program evaluation
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

This study's planned enrollment of 400 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 568 studies on the registry; 81 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

STOMP Group:12-17 yrs. Patients in the program have severe complex obesity defined as children and youth who have a BMI >95th %ile for their age and gender in addition to one of the following: at least one significant obesity-related co-morbidity requiring specialty care (e.g. type 2 diabetes), other co-existing chronic illness impacted by obesity (e.g. CNS tumor, post-organ transplant), or a BMI ≥99th percentile for their age and gender Control: Approximately 50% of attendees choose not to book into the program, for reasons including difficulty attending the frequent appointments due to distance or inability to leave work early. This population will serve as the control group for the evaluation. Control participants will be recruited from the community through posters in the hospital.

Inclusion criteria

  • All patients enrolled in the STOMP program are eligible to participate in the study.
  • Control participants must be between 12-18 years of age with a BMI >95th percentile for age.

Exclusion criteria

Exclusion Criteria:

  • Control participants cannot be enrolled in the STOMP program.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
400 participants (estimated)

Groups and cohorts

  • Control

    Approximately 50% of attendees choose not to book into the STOMP program, for reasons including difficulty attending the frequent appointments due to distance or inability to leave work early. This population will serve as the control group for the evaluation. Control participants will be recruited from the community through posters in the hospital

  • STOMP

    12-17 yrs. Patients in the program have severe complex obesity defined as children and youth who have a BMI \>95th %ile for their age and gender in addition to one of the following: at least one significant obesity-related co-morbidity requiring specialty care (e.g. type 2 diabetes), other co-existing chronic illness impacted by obesity (e.g. CNS tumor, post-organ transplant), or a BMI ≥99th percentile for their age and gender

    Behavioral: STOMP Clinic

Interventions

  • BehavioralSTOMP Clinic

    A new interdisciplinary clinic (STOMP) was created to provide care for children and adolescents with severe 'complex' obesity. As part of the program, a subset of adolescents undergo bariatric surgery. The core elements include an interdisciplinary team, frequent visits, individualized care plans for medically-complex adolescents) and building on other aspects, such as increased psychosocial intervention; involvement of a "key worker" (nurse practitioner) to support families; provision of continuity of care with other health providers in all settings, community services and schools; a more diverse patient population; and group support sessions.

06

What researchers measure

Primary outcomes

  1. Body Mass Index

    BMI will be measured at Baseline and 12 months after treatment to evaluate change

    Time frame: Baseline

  2. Body Mass Index

    BMI will be measured at Baseline and 12 months after treatment to evaluate change

    Time frame: 12 months

Secondary outcomes

  1. Systolic and Diastolic Blood Pressure

    Systolic and Diastolic Blood Pressure will be measured at Baseline and 12 months after treatment to evaluate change

    Time frame: Baseline, 12 months

  2. Lipid profile

    The lipid profile (including total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides) will be measured at Baseline and 12 months after treatment to evaluate change

    Time frame: Baseline and 12 months

  3. Glycemic control and Insulin resistance

    Glycemic control will be measured by HbA1c values and insulin resitance will be assed by HOMA-IR

    Time frame: Baseline and 12 months

  4. Health and weight-related quality of life

    This outcome measure will be assessed by the Pediatric Quality of Life Inventory (PedsQL)) and the impact of Weight on Quality of Life (IWQOL)

    Time frame: Baseline and 12 months

07

Study locations

1 of 1 sites recruiting
  • The Hospital for Sick Children
    Toronto, Ontario M5V1X8, Canada
    • Jill Hamilton, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01515904
Lead sponsor
The Hospital for Sick Children
Responsible party
Jill Hamilton (Staff Endocrinologist, The Hospital for Sick Children) — Principal investigator
First posted
Jan 24, 2012
Start date
Apr 2011
Primary completion
Apr 2025 (estimated)
Completion
Apr 2028 (estimated)
Last update
Sep 13, 2022

Study contacts

Jill Hamilton
Contact
jill.hamilton@sickkids.ca
416-813-5115 ext. 205115
Jill Hamilton, MD
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion